Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation

Area of Science:

• Immunology
• Rheumatology
• Molecular Biology

Background:

• Rheumatoid factor (RF) is an autoantibody often found in autoimmune diseases.
• Antibody/double-stranded DNA immune complexes are implicated in the pathogenesis of systemic lupus erythematosus (SLE).
• Complement system activation plays a critical role in immune complex-mediated inflammation.

Purpose of the Study:

• To investigate the effect of RF on complement-mediated binding of antibody/double-stranded DNA immune complexes to red blood cells.
• To elucidate the mechanism by which RF influences this binding process.
• To assess the potential role of RF in exacerbating lupus nephritis.

Main Methods:

• Immune complex preparation using purified antibodies and double-stranded DNA.
• Complement fixation assays.
• Measurement of immune complex binding to erythrocytes (red blood cells).
• Assessment of RF's interaction with complement components.

Main Results:

• Rheumatoid factor significantly enhances the binding of antibody/double-stranded DNA immune complexes to red blood cells.
• This enhancement is mediated by the Fc region of RF, which appears to fix complement.
• The presence of RF leads to increased complement deposition on red blood cells.

Conclusions:

• Rheumatoid factor plays a crucial role in amplifying complement-mediated immune complex deposition.
• RF may act as an exacerbating factor in the development and progression of antibody/DNA-induced glomerulonephritis in systemic lupus erythematosus.
• Targeting RF or its interaction with complement could be a potential therapeutic strategy for SLE patients.